10
Participants
Start Date
June 30, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
August 31, 2015
NS-065/NCNP-01
"NS-065/NCNP-01 for Infusion is packaged as 25 mg/mL in phosphate buffered saline with 1 mL per vial. Study dosages will be infused over a 1 hour period with Normal saline as follows:~Cohort 1: 1.25mg/kg once weekly for 12 weeks; Cohort 2: 5.0mg/kg once weekly for 12 weeks; Cohort 3: 20.0mg/kg once weekly for 12 weeks"
National Center of Neurology and Psychiatry, Kodaira
Collaborators (1)
Nippon Shinyaku Co., Ltd.
INDUSTRY
National Center of Neurology and Psychiatry, Japan
OTHER